GT Biopharma
GTBP
GTBP
50 hedge funds and large institutions have $69.7M invested in GT Biopharma in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
50
Holders Change
+29
Holders Change %
+138.1%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
9
Reduced
4
Closed
4
Calls
$9K
Puts
–
Net Calls
+$9K
Net Calls Change
+$9K
Top Buyers
1 |
1
BlackRock
New York
|
$21.9M |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$15.2M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$7.91M |
4 |
4
State Street
Boston,
Massachusetts
|
$5.81M |
5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$5.37M |